Tenet Healthcare Corporation (THC) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Tenet Healthcare Corporation (THC) carries a Roarable Rating of C+ (Hold) with 66/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How THC Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $21.31B | 44% | 16.5% | $2.37B | $2.53B | 26% |
| FY 2024 | $20.68B | 44% | 28.8% | $4.06B | $1.12B | 45.6% |
| FY 2023 | $20.56B | 44% | 12.2% | $1.31B | $1.45B | 13.3% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring THC)
- ✓Live walkthrough of THC's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
THC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +3.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on THC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for THC. Explore sector supply chains on /butterfly.
THC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Tenet Healthcare Corporation (THC)?
In FY 2025 (10-K), THC converted $21.3B of revenue into a 44% gross margin, 16.5% operating margin, and $2.5B in free cash flow (11.9% FCF margin).